About REGENICIN INC
Regenicin, Inc. is a biotechnology company founded in 2010 that specializes in developing regenerative cell therapies to restore damaged tissues and organs. They are pioneering treatments like NovaDerm, a cultured skin substitute for severe burns.
Development of regenerative cell therapiesCultured cell technology for tissue engineeringProduction of NovaDerm, a living tissue-engineered skin substitute
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to REGENICIN INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.